Hyper-coagulation,
hypothermia, systemic inflammatory responses and
shock are major clinical manifestations of
endotoxin shock syndrome in human. As previously reported, mice primed with heat-killed Propionibacterium acnes are highly susceptible to the action of LPS to induce tumour
necrosis factor (
TNF)-alpha and to that of
TNF-alpha to trigger lethal
shock. Here we investigated the mechanisms underlying the P. acnes-induced sensitization to LPS and
TNF-alpha and the development of individual symptoms after subsequent challenge with LPS or
TNF-alpha. Propionibacterium acnes-primed wild-type (WT) mice, but not naive mice, exhibited hyper-coagulation with elevated levels of
thrombin-
antithrombin complexes and anti-fibrinolytic
plasminogen activator inhibitor 1 in their plasma,
hypothermia, systemic inflammatory responses and high mortality rate after LPS or
TNF-alpha challenge. Propionibacterium acnes treatment reportedly induces both T(h)1 and T(h)17 cell development. Propionibacterium acnes-primed Il12p40(-/-) and Ifngamma(-/-) mice, while not Il17A(-/-) mice, evaded all these symptoms/signs upon LPS or
TNF-alpha challenge, indicating essential requirement of IL-12-IFN-gamma axis for the sensitization to LPS and
TNF-alpha. Furthermore, IFN-gamma blockade just before LPS challenge could prevent P. acnes-primed WT mice from
endotoxin shock syndrome. These results demonstrated requirement of IFN-gamma to the development of
endotoxin shock and suggested it as a potent therapeutic target for the treatment of
septic shock.